Literature DB >> 17422267

Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony.

P J O'brien, P H Cribb, R J White, E D Olfert, J E Steiss.   

Abstract

Fifteen related dogs were studied for susceptibility to malignant hyperthermia using halothane challenge and caffeine contracture tests. These dogs had hypertrophied muscles, were of a nervous temperament and had rectal temperatures at the upper limit of the normal range. Clinical pathology findings were mild elevations of serum aspartate transaminase and mean corpuscular hemoglobin. In vitro caffeine contracture tests were performed on muscle biopsies from five of these dogs. The concentration of caffeine required to increase resting tension by 1 g in biopsy specimens of these dogs was significantly lower than that required for control dogs: 7.6 +/- 1.38 (x +/- SEM) versus 15.5 +/- 2.52 mM (P < 0.025), and in the presence of 1% halothane, 3.6 +/- 1.44 versus 10.6 +/- 2.19 mM (P < 0.05). Internal nuclei, fiber caliber variation and fiber hypertrophy were found in histological studies of muscle biopsies. Two other dogs possibly died of a canine stress syndrome analagous to the porcine stress syndrome which occurs in malignant hyperthermia susceptible swine. Eight others of this family were anesthetized with halothane or methoxyflurane. Methoxyflurane did not trigger the syndrome. The first exposure to halothane caused death from malignant hyperthermia in two dogs and a third died on the second exposure to halothane. Postmortem findings were nonspecific. The other three dogs exposed to halothane recovered uneventfully. Inheritance of the defect conforms to a multifactorial pattern, with gradations of susceptibility.

Entities:  

Year:  1983        PMID: 17422267      PMCID: PMC1790357     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  36 in total

1.  The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.

Authors:  G G Harrison
Journal:  Br J Anaesth       Date:  1977-04       Impact factor: 9.166

2.  Malignant hyperthermia in a Greyhound.

Authors:  R J Bagshaw; R H Cox; D H Knight; D K Detweiler
Journal:  J Am Vet Med Assoc       Date:  1978-01-01       Impact factor: 1.936

3.  Comparison of effects of several inhalation anaesthetics on caffeine-induced contractures of normal and malignant hyperthermic skeletal muscle.

Authors:  B A Britt; L Endrenyi; W Frodis; E Scott; W Kalow
Journal:  Can Anaesth Soc J       Date:  1980-01

4.  Dantrolene and caffeine contracture test.

Authors:  W Lambert
Journal:  Can Anaesth Soc J       Date:  1980-05

5.  Parvovirus infection and distemper vaccination.

Authors:  L T Glickman; M J Appel
Journal:  J Am Vet Med Assoc       Date:  1981-05-15       Impact factor: 1.936

6.  Acepromazine and droperidol inhibition of halothane-induced malignant hyperthermia (porcine stress syndrome) in swine.

Authors:  C J McGrath; W E Rempel; P B Addis; A J Crimi
Journal:  Am J Vet Res       Date:  1981-02       Impact factor: 1.156

7.  Dantrolene and the treatment of malignant hyperthermia.

Authors:  G M Hall
Journal:  Br J Anaesth       Date:  1980-09       Impact factor: 9.166

8.  Puzzles in malignant hyperthermia.

Authors:  G A Gronert
Journal:  Anesthesiology       Date:  1981-01       Impact factor: 7.892

9.  Malignant hyperthermia in a greyhound.

Authors:  C A Cohen
Journal:  J Am Vet Med Assoc       Date:  1978-06-01       Impact factor: 1.936

10.  Role of plasma membrane defect of skeletal muscle in malignant hyperthermia.

Authors:  E M Gallant; R E Godt; G A Gronert
Journal:  Muscle Nerve       Date:  1979 Nov-Dec       Impact factor: 3.217

View more
  11 in total

1.  Malignant hyperthermia in dogs.

Authors:  P J O'brien
Journal:  Can Vet J       Date:  1987-06       Impact factor: 1.008

2.  Ontario. Canine stress syndrome.

Authors:  B I Kalow; P J O'brien
Journal:  Can Vet J       Date:  1989-07       Impact factor: 1.008

Review 3.  Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

Review 4.  The paradox of muscle hypertrophy in muscular dystrophy.

Authors:  Joe N Kornegay; Martin K Childers; Daniel J Bogan; Janet R Bogan; Peter Nghiem; Jiahui Wang; Zheng Fan; James F Howard; Scott J Schatzberg; Jennifer L Dow; Robert W Grange; Martin A Styner; Eric P Hoffman; Kathryn R Wagner
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-02       Impact factor: 1.784

Review 5.  Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis.

Authors:  P J O'Brien; A Klip; B A Britt; B I Kalow
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

6.  Microassay for malignant hyperthermia susceptibility: hypersensitive ligand-gating of the Ca channel in muscle sarcoplasmic reticulum causes increased amounts and rates of Ca-release.

Authors:  P J O'Brien
Journal:  Mol Cell Biochem       Date:  1990-03-05       Impact factor: 3.396

7.  Pharmacokinetic evaluation of oral dantrolene in the dog.

Authors:  J L Haraschak; V C Langston; R Wang; C Riggs; C Fellman; M K Ross; C Bulla; K Lunsford; A Mackin; T Archer
Journal:  J Vet Pharmacol Ther       Date:  2013-11-13       Impact factor: 1.786

8.  Rapid, simple and sensitive microassay for skeletal and cardiac muscle myoglobin and hemoglobin: use in various animals indicates functional role of myohemoproteins.

Authors:  P J O'Brien; H Shen; L J McCutcheon; M O'Grady; P J Byrne; H W Ferguson; M S Mirsalimi; R J Julian; J M Sargeant; R R Tremblay
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

9.  Malignant hyperthermia susceptibility: cardiac histomorphometry of dogs and young and market-weight swine.

Authors:  P J O'Brien; T F Fletcher; A L Metz; H J Kurtz; B K Reed; W E Rempel; E G Clark; C F Louis
Journal:  Can J Vet Res       Date:  1987-01       Impact factor: 1.310

10.  Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.

Authors:  P J O'Brien; G W Forsyth; D W Olexson; H S Thatte; P B Addis
Journal:  Can J Comp Med       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.